AlphaFold predicted structure
ASS1 · P00966

Mean pLDDT
95.5/ 100
Very high
412 residues
Confidence breakdown
- Very high(≥ 90)91%
- Confident(70–90)7%
- Low(50–70)2%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
argininosuccinate synthase 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
citrullinemia type I
citrullinemia
hereditary disease
acute neonatal citrullinemia type I
Intellectual disability
adult-onset citrullinemia type I
citrullinemia type II
disturbances of sensation of smell and taste
autoimmune disorder of central nervous system
alcohol drinking
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Argininosuccinate synthase
One of the enzymes of the urea cycle, the metabolic pathway transforming neurotoxic amonia produced by protein catabolism into inocuous urea in the liver of ureotelic animals. Catalyzes the formation of arginosuccinate from aspartate, citrulline and ATP and together with ASL it is responsible for the biosynthesis of arginine in most body tissues
ASS1 · P00966

Mean pLDDT
95.5/ 100
Very high
412 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0